Quoin Pharmaceuticals announces FDA rare pediatric designation for QRX003
QNRX correction: Quoin Pharmaceuticals said the FDA granted rare pediatric disease designation for QRX003 in peeling skin syndrome.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
QNRX gets FDA rare pediatric disease designation for QRX003
Quoin Pharmaceuticals said the FDA granted rare pediatric disease designation for QRX003 in peeling skin syndrome.